Persistent CD19+ B cell lymphopenia in critically ill COVID-19 patients 50 days after symptom onset
Our findings indicate that aberrant immune cell profiles in COVID-19 patients change dynamically during recovery, depending on disease severity. This study suggests that convalescent patients from critical COVID-19 may experience long-lasting B-cell lymphopenia.
Authors
- Yongyu Wang (ORCID: https://orcid.org/0000-0002-6088-8887)
- Shengwei Jin (ORCID: https://orcid.org/0000-0002-4734-8114)
- Hao Hu (ORCID: https://orcid.org/0000-0002-1103-0243)
- Xinyue Zhang (ORCID: https://orcid.org/0000-0002-4243-083X)
- Chen Zhang (ORCID: https://orcid.org/0000-0002-9461-1755)
- Ting Li (ORCID: https://orcid.org/0009-0005-1779-6943)
- Hui Jeong An
- Ming Li (ORCID: https://orcid.org/0009-0002-3553-6932)
Institutions
- Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2024-11-22
- DOI
- https://doi.org/10.3389/fcimb.2024.1488607
- Citations
- 1
- Primary Topic
- Long-Term Effects of COVID-19
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- National Natural Science Foundation of China
- Wenzhou Municipal Science and Technology Bureau
- Natural Science Foundation of Zhejiang Province